Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Discover how to make zero based budget adjustments in response to changes in income. Maintain your financial stability today.
23,257 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
The quantum funding wave from Washington exposes a stark split: IonQ’s rapid revenue growth against IBM’s cash machin...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
Nvidia just landed a significant AI deal that could shift its growth trajectory. This article breaks down what invest...
Bitunix unveils a Visa-powered debit card allowing users to spend crypto worldwide and earn yields. The card integrat...
Intraday spikes can be thrilling, but they’re not always meaningful. Learn why a stock popped today then often retrea...
IonQ stock surged today after the company issued a revenue forecast that beat expectations, sparking a rally in the q...
When a niche tech stock makes a big leap, investors want to know why. This deep dive explains the factors behind IPG ...
SpaceX’s planned IPO could force immediate inclusion in Nasdaq-100 ETFs, igniting volatility for QQQ and other tracke...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...
The AI rally cooled, but the opportunity remains. This guide shares three AI stocks investors should load up on and a...
IonQ just posted revenue that more than tripled for the third straight quarter, but the stock sold off despite the ga...